Frequencies for first 10,000 rows of dose_form variable in drug2017q1 dataset : Form of dose reported | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 5,701 57.01 57.01 CAPSULE | 322 3.22 60.23 CAPSULE, HARD | 106 1.06 61.29 CAPSULE, SOFT | 2 0.02 61.31 CAPSULES | 85 0.85 62.16 CHEWABLE TABLET | 6 0.06 62.22 COATED TABLET | 25 0.25 62.47 CONCENTRATE FOR SOLUTION FOR INFUSION | 27 0.27 62.74 CREAM | 8 0.08 62.82 DROPS | 2 0.02 62.84 DRY POWDER INHALER | 4 0.04 62.88 EYE DROPS | 2 0.02 62.90 EYE DROPS, SOLUTION | 10 0.10 63.00 EYE DROPS, SUSPENSION | 1 0.01 63.01 FILM COATED TABLET | 2 0.02 63.03 FILM-COATED TABLET | 245 2.45 65.48 FORMULATION UNKNOWN | 66 0.66 66.14 GASTRO-RESISTANT CAPSULE, HARD | 6 0.06 66.20 GASTRO-RESISTANT TABLET | 2 0.02 66.22 GEL | 4 0.04 66.26 GRANULATE | 1 0.01 66.27 GRANULES | 14 0.14 66.41 IMPLANT | 2 0.02 66.43 INFUSION | 20 0.20 66.63 INHALATION | 3 0.03 66.66 INHALATION POWDER | 27 0.27 66.93 INHALATION POWDER, HARD CAPSULE | 3 0.03 66.96 INHALATION SOLUTION | 1 0.01 66.97 INHALATION VAPOUR | 4 0.04 67.01 INHALATION VAPOUR, SOLUTION | 8 0.08 67.09 INJECTION | 181 1.81 68.90 INJECTION FOR INFUSION | 8 0.08 68.98 INTRAUTERINE DELIVERY SYSTEM | 7 0.07 69.05 INTRAVENOUS INFUSION | 5 0.05 69.10 INVESTIGATIONAL DOSAGE FORM | 4 0.04 69.14 JELLY | 1 0.01 69.15 LIPOSOME INJECTION | 5 0.05 69.20 LIQUID | 2 0.02 69.22 LOTION | 3 0.03 69.25 LYOPHILIZED POWDER | 32 0.32 69.57 MATRIX PATCH | 3 0.03 69.60 MICROSPHERES | 2 0.02 69.62 MODIFIED-RELEASE CAPSULE, HARD | 7 0.07 69.69 MODIFIED-RELEASE TABLET | 18 0.18 69.87 NASAL SPRAY | 10 0.10 69.97 NASAL SPRAY, SUSPENSION | 1 0.01 69.98 NEBULISER SOLUTION | 1 0.01 69.99 NEBULISER SUSPENSION | 6 0.06 70.05 OINTMENT | 9 0.09 70.14 OINTMENT, CREAM | 1 0.01 70.15 ORAL DROPS | 1 0.01 70.16 ORAL SOLUTION | 1 0.01 70.17 ORODISPERSIBLE TABLET | 8 0.08 70.25 OROS (ORAL OSMOTIC) THERAPEUTIC SYSTE.. | 7 0.07 70.32 PATCH | 19 0.19 70.51 PER ORAL NOS | 111 1.11 71.62 PILLULES | 1 0.01 71.63 POWDER (EXCEPT [DPO]) | 2 0.02 71.65 POWDER AND SOLVENT FOR SOLUTION FOR I.. | 19 0.19 71.84 POWDER FOR INFUSION | 33 0.33 72.17 POWDER FOR INJECTION | 31 0.31 72.48 POWDER FOR ORAL SOLUTION | 2 0.02 72.50 POWDER FOR SOL FOR INJ | 1 0.01 72.51 POWDER FOR SOLUTION FOR INFUSION | 3 0.03 72.54 POWDER FOR SOLUTION FOR INJECTION | 23 0.23 72.77 PRESSURISED INHALATION, SUSPENSION | 1 0.01 72.78 PROLONGED-RELEASE CAPSULE | 4 0.04 72.82 PROLONGED-RELEASE TABLET | 160 1.60 74.42 SHAMPOO | 1 0.01 74.43 SOLUTION | 11 0.11 74.54 SOLUTION FOR INFUSION | 275 2.75 77.29 SOLUTION FOR INJECTION | 356 3.56 80.85 SOLUTION FOR INJECTION IN PRE-FILLED .. | 16 0.16 81.01 SOLUTION FOR INJECTION IN PRE-FILLED .. | 97 0.97 81.98 SOLUTION FOR INJECTION/INFUSION | 3 0.03 82.01 SPRAY (NOT INHALATION) | 1 0.01 82.02 SUBCUTANEOUS INJECTION | 1 0.01 82.03 SUPPOSITORY | 3 0.03 82.06 SUSPENSION | 14 0.14 82.20 SUSPENSION FOR INJECTION | 1 0.01 82.21 SUSTAINED RELEASE TABLETS | 1 0.01 82.22 TABLET | 1,142 11.42 93.64 TABLETS | 72 0.72 94.36 TRANSDERMAL PATCH | 12 0.12 94.48 UNKNOWN | 374 3.74 98.22 UNKNOWN FORMULATION | 16 0.16 98.38 UNSPECIFIED | 151 1.51 99.89 VAGINAL CREAM | 3 0.03 99.92 VIAL | 8 0.08 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Sep 2017